Pure Global

MAGLUMI Anti-Cardiolipin (CLIA) - Indonesia BPOM Medical Device Registration

MAGLUMI Anti-Cardiolipin (CLIA) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20305520024. The device is manufactured by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. SNIBE DIAGNOSTIC INDONESIA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
MAGLUMI Anti-Cardiolipin (CLIA)
Analysis ID: AKL 20305520024

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

PT. SNIBE DIAGNOSTIC INDONESIA

AR Address

TEMPO SCAN TOWER, LANTAI 21, JALAN H.R. RASUNA SAID KAV. 3-4

Registration Date

Jan 09, 2025

Expiry Date

Oct 30, 2029

Product Type

Immunological Test System

Multiple autoantibodies immunological test system.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing